CC BY-NC-ND 4.0 · Thromb Haemost 2022; 122(10): 1837-1842
DOI: 10.1055/a-1863-7265
DOI: 10.1055/a-1863-7265
Letter to the Editor
Autoimmune Acquired Factor XIII/13 Deficiency after SARS-CoV-2 mRNA Vaccination
Shingen Nakamura
1
Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
,
Motoki Sugasaki
2
Department of Medical Technology, Tokushima University Hospital, Tokushima, Japan
,
Masayoshi Souri
3
Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan
4
The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies, Yamagata, Japan
,
Hirohito Akazawa
5
Department of Dermatology, Anan Medical Center, Tokushima, Japan
,
Maiko Sogawa
5
Department of Dermatology, Anan Medical Center, Tokushima, Japan
,
Taiki Hori
6
Department of Internal Medicine, Anan Medical Center, Tokushima, Japan
,
Hiroki Yamagami
6
Department of Internal Medicine, Anan Medical Center, Tokushima, Japan
,
Makoto Takishita
6
Department of Internal Medicine, Anan Medical Center, Tokushima, Japan
,
Ken-ichi Aihara
1
Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
,
Masahiro Abe
7
Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
,
Atsushi Yasumoto
8
Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Hokkaido, Japan
,
Eriko Morishita
9
Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan
,
Akitada Ichinose
3
Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan
4
The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies, Yamagata, Japan
› Institutsangaben
